Gastrointestinal Cancer News

The FDA granted priority review to futibatinib for treatment of certain patients with cholangiocarcinoma.

A wait time of at least 20 days to undergo elective, low-risk, cancer-related surgery appeared safe following recovery from mild to moderate COVID-19, according to study results published in Annals of Surgical Oncology.

More than 70% of patients with metastatic colorectal cancer bore financial hardships within the first year of diagnosis despite most having health insurance, according to study results published in Journal of the National Cancer Institute.

The University of Texas MD Anderson Cancer announced Thursday the launch of the James P. Allison Institute, a research and innovation hub that integrates immunobiology across disciplines to accelerate discoveries toward cancer cures.

In this episode, Richard L. Schilsky, FSCT, FASCO, FACP, MD, discusses his involvement with ASCO, ideas for making a more equitable health care system and thoughts on the current state of oncology.

Cancer screening remains in need of urgent attention, and online resources may help facilities close gaps and address screenings missed in 2020, according to a prospective quality improvement study published in Cancer.

Artificial intelligence-assisted colonoscopy reduced the colorectal neoplasia miss rate by nearly twofold compared with colonoscopy alone, according to research published in Gastroenterology.

Nonalcoholic fatty liver disease correlated with lower hepatocellular carcinoma surveillance receipt, early-stage detection and poorer survival compared with other HCC etiologies, according to research.

For National Colorectal Cancer Awareness Month, Healio presents a collection of videos, Q&As and new data that details improved access to CRC care, the importance of early screening, updated guidelines and more.

As important as the care of Ukrainian citizens with cancer is to clinicians in that country, this priority has been overshadowed by more immediate concerns.